Trade Summary

2 months ago, Enright Patrick G, serving as Dir at Zenas Biopharma, Inc. (ZBIO), purchased 117,255 shares at $19.19 per share, for a total transaction value of $2,250,027.00. Following this transaction, Enright Patrick G now holds 2,619,189 shares of ZBIO.

This purchase represents a 5.00% increase in Enright Patrick G's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, October 9, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, October 14, 2025, 5 days after the trade was made.

Zenas Biopharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.